Cannabis-based Medicines Debate

Full Debate: Read Full Debate
Department: Home Office

Cannabis-based Medicines

Jeff Smith Excerpts
Tuesday 19th June 2018

(5 years, 10 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Sajid Javid Portrait Sajid Javid
- Hansard - - - Excerpts

I can absolutely give my hon. Friend that reassurance. The review must have the patient at its very heart and must be driven by medical evidence.

Jeff Smith Portrait Jeff Smith (Manchester, Withington) (Lab)
- Hansard - -

I welcome the statement, and particularly the news on Alfie Dingley. Of course, there is already evidence of the medical benefits of cannabis, because otherwise Sativex would not be available on licence. That is why it is so absurd that cannabis is still a schedule 1 controlled drug. I am therefore hopeful and confident that the review will lead to a recommendation to reschedule. Will the Secretary of State confirm that rescheduling could be carried out quite quickly and easily by means of a statutory instrument, meaning that we can get on with it?

Sajid Javid Portrait Sajid Javid
- Hansard - - - Excerpts

First, Sativex was looked at for a particular condition. It is right that drugs are looked at the context of the condition that they are intended to help with. The hon. Gentleman makes a good wider point about whether, once the review is complete, we can get on with it, with any changes made quickly. That is exactly what I intend to do.